A novel screening test for colon cancer: Talin-1

Eur Rev Med Pharmacol Sci. 2014;18(17):2533-7.

Abstract

Objective: Cell adhesion and angiogenesis within the extracellular matrix involve special signaling molecules, such as integrins and the actin binding protein Talin-1. The aim of this study was to investigate and describe the expression of Talin-1 for the early detection of colon cancer.

Patients and methods: Blood serum samples were collected from 50 healthy volunteers and from 90 patients with colon cancer. Using an enzyme-linked immunosorbent assay (ELISA), all 140 samples were analyzed.

Results: Preoperative levels of Talin-1 in the serum were significantly higher in patients with colon cancer (p < 0.001). No significant correlation was found between preoperative levels of Talin-1 in the serum and the age and gender of the patients (p < 0.05). However, a significant correlation was found between Talin-1 levels and the tumor grade, TNM stage, and lymph node metastasis (p < 0.001).

Conclusions: Talin-1 may play a role in the reinforcement of cell proliferation, cell adhesion, and angiogenesis in colon cancer. Thus, the Talin-1 protein activity may be a novel biomarker to detect colon cancer in humans.

Publication types

  • Multicenter Study

MeSH terms

  • Biomarkers, Tumor / biosynthesis
  • Biomarkers, Tumor / blood
  • Cell Adhesion / physiology
  • Colonic Neoplasms / blood*
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / pathology
  • Early Detection of Cancer / methods
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Talin / biosynthesis
  • Talin / blood*

Substances

  • Biomarkers, Tumor
  • TLN1 protein, human
  • Talin